Insider · CIK 0001200469

YEAMAN KEVIN J

Reports to the SEC for 2 companies · SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001200469

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-02-05	DLBDolby Laboratories, Inc. · Employee Stock Option (Right to Buy)G Gift	Director, President and CEO	GGift	−145K sh	—	—	145,252
2026-02-05	DLBDolby Laboratories, Inc. · Employee Stock Option (Right to Buy)G Gift	Director, President and CEO	GGift	+145K sh	—	—	145,252
2025-12-17	DLBDolby Laboratories, Inc.S Sale	Director, President and CEO	SSale	−6,671 sh	$67.24	−$449K	98,457
2025-12-17	DLBDolby Laboratories, Inc.S Sale	Director, President and CEO	SSale	−80 sh	$67.54	−$5,403.2	98,377
2025-12-16	DLBDolby Laboratories, Inc.F Tax Payment	Director, President and CEO	FTax Payment	−6,855 sh	$66.62	−$457K	143,784
2025-12-16	DLBDolby Laboratories, Inc.S Sale	Director, President and CEO	SSale	−21.8K sh	$66.64	−$1.45M	110,122
2025-12-16	DLBDolby Laboratories, Inc.S Sale	Director, President and CEO	SSale	−4,994 sh	$67.16	−$335K	105,128
2025-12-15	DLBDolby Laboratories, Inc.A Award	Director, President and CEO	AAward	+66K sh	—	—	193,703
2025-12-15	DLBDolby Laboratories, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+17.6K sh	—	—	202,587
2025-12-15	DLBDolby Laboratories, Inc.F Tax Payment	Director, President and CEO	FTax Payment	−27.2K sh	$67.54	−$1.84M	157,390
2025-12-15	DLBDolby Laboratories, Inc. · Performance-Based Restricted Stock UnitA Award	Director, President and CEO	AAward	+33K sh	—	—	32,984
2025-12-15	DLBDolby Laboratories, Inc. · Employee Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+145K sh	—	—	145,252
2025-12-15	DLBDolby Laboratories, Inc. · Performance-Based Restricted Stock UnitM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−17.6K sh	—	—	0
2025-12-09	DLBDolby Laboratories, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+10.6K sh	$64.60	+$686K	108,992
2025-12-09	DLBDolby Laboratories, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+23.8K sh	$45.50	+$1.08M	132,744
2025-12-09	DLBDolby Laboratories, Inc.S Sale	Director, President and CEO	SSale	−28.2K sh	$66.99	−$1.89M	104,576
2025-12-09	DLBDolby Laboratories, Inc.S Sale	Director, President and CEO	SSale	−6,199 sh	$67.51	−$418K	98,377
2025-12-09	DLBDolby Laboratories, Inc. · Employee Stock Option (Right to Buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−10.6K sh	—	—	0
2025-12-09	DLBDolby Laboratories, Inc. · Employee Stock Option (Right to Buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−23.8K sh	—	—	0
2025-11-26	DLBDolby Laboratories, Inc.G Gift	Director, President and CEO	GGift	−16.3K sh	—	—	98,377
2025-11-24	DLBDolby Laboratories, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+25K sh	$45.50	+$1.14M	139,725
2025-11-24	DLBDolby Laboratories, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+11.7K sh	$64.60	+$756K	151,424
2025-11-24	DLBDolby Laboratories, Inc.S Sale	Director, President and CEO	SSale	−36.7K sh	$66.91	−$2.46M	114,725
2025-11-24	DLBDolby Laboratories, Inc. · Employee Stock Option (Right to Buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−25K sh	—	—	10,615
2025-11-24	DLBDolby Laboratories, Inc. · Employee Stock Option (Right to Buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−11.7K sh	—	—	23,752
2025-10-14	DLBDolby Laboratories, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+25K sh	$45.50	+$1.14M	139,725
2025-10-14	DLBDolby Laboratories, Inc.S Sale	Director, President and CEO	SSale	−11.2K sh	$68.51	−$768K	128,511
2025-10-14	DLBDolby Laboratories, Inc.S Sale	Director, President and CEO	SSale	−13.8K sh	$69.17	−$954K	114,725
2025-10-14	DLBDolby Laboratories, Inc. · Employee Stock Option (Right to Buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−25K sh	—	—	35,615
2025-09-16	DLBDolby Laboratories, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+25K sh	$45.50	+$1.14M	139,725
2025-09-16	DLBDolby Laboratories, Inc.S Sale	Director, President and CEO	SSale	−25K sh	$71.66	−$1.79M	114,725
2025-09-16	DLBDolby Laboratories, Inc. · Employee Stock Option (Right to Buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−25K sh	—	—	60,615
2025-08-12	DLBDolby Laboratories, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+25K sh	$45.50	+$1.14M	139,725
2025-08-12	DLBDolby Laboratories, Inc.S Sale	Director, President and CEO	SSale	−25K sh	$72.31	−$1.81M	114,725
2025-08-12	DLBDolby Laboratories, Inc. · Employee Stock Option (Right to Buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−25K sh	—	—	85,615
2025-07-16	DLBDolby Laboratories, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+2,491 sh	$64.60	+$161K	117,216
2025-07-16	DLBDolby Laboratories, Inc.S Sale	Director, President and CEO	SSale	−2,491 sh	$75.00	−$187K	114,725
2025-07-16	DLBDolby Laboratories, Inc. · Employee Stock Option (Right to Buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−2,491 sh	—	—	35,451
2025-07-15	DLBDolby Laboratories, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+25K sh	$45.50	+$1.14M	139,725
2025-07-15	DLBDolby Laboratories, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+14.9K sh	$64.60	+$961K	154,600
2025-07-15	DLBDolby Laboratories, Inc.S Sale	Director, President and CEO	SSale	−39.6K sh	$74.81	−$2.96M	115,005
2025-07-15	DLBDolby Laboratories, Inc.S Sale	Director, President and CEO	SSale	−280 sh	$75.30	−$21.1K	114,725
2025-07-15	DLBDolby Laboratories, Inc. · Employee Stock Option (Right to Buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−25K sh	—	—	110,615
2025-07-15	DLBDolby Laboratories, Inc. · Employee Stock Option (Right to Buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−14.9K sh	—	—	37,942
2025-06-24	DLBDolby Laboratories, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+25K sh	$45.50	+$1.14M	139,725
2025-06-24	DLBDolby Laboratories, Inc.S Sale	Director, President and CEO	SSale	−25K sh	$74.02	−$1.85M	114,725
2025-06-24	DLBDolby Laboratories, Inc. · Employee Stock Option (Right to Buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−25K sh	—	—	135,615
2025-06-10	DLBDolby Laboratories, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+25K sh	$45.50	+$1.14M	139,725
2025-06-10	DLBDolby Laboratories, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+8,683 sh	$64.60	+$561K	148,408
2025-06-10	DLBDolby Laboratories, Inc.S Sale	Director, President and CEO	SSale	−33.5K sh	$76.22	−$2.55M	114,904

Recent filings

Accepted (ET)
Feb 94
YEAMAN KEVIN J0001193125-26-042838
SEC(opens sec.gov)
Dec 174
YEAMAN KEVIN J0001193125-25-323431
SEC(opens sec.gov)
Dec 114
YEAMAN KEVIN J0001193125-25-316180
SEC(opens sec.gov)
Nov 264
YEAMAN KEVIN J0001193125-25-301000
SEC(opens sec.gov)

Companies

Address

C/O DOLBY LABORATORIES, INC. 1275 MARKET STREET

SAN FRANCISCO, CA, 94103